[{"address1": "4868 Rue Levy", "address2": "Suite 220", "city": "Montreal", "state": "QC", "zip": "H4R 2P1", "country": "Canada", "phone": "514 332 4888", "website": "https://www.engene.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Gu\u00e9rin (BCG). The company is based in Montreal, Canada.", "fullTimeEmployees": 31, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alex  Nichols Ph.D.", "age": 38, "title": "Chief Strategy & Operations Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 504442, "exercisedValue": 0, "unexercisedValue": 3900970}, {"maxAge": 1, "name": "Mr. Ronald H. W. Cooper", "age": 60, "title": "Chief Executive Officer & Director", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anthony T. Cheung Ph.D.", "age": 51, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 341754, "exercisedValue": 0, "unexercisedValue": 13448566}, {"maxAge": 1, "name": "Mr. John C. Brown D.Sc., FRSC, Ph.D.", "title": "Co-Founder and Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Ryan Daws", "age": 49, "title": "CFO & Head of Business Development", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Joan  Connolly", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lee G. Giguere", "age": 42, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sharon  Tan", "title": "VP of Project Management & Head of Program Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raj  Pruthi F.A.C.S., M.D., M.H.A.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Erickson", "title": "Non-Executive Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.96, "open": 6.54, "dayLow": 5.6, "dayHigh": 6.54, "regularMarketPreviousClose": 5.96, "regularMarketOpen": 6.54, "regularMarketDayLow": 5.6, "regularMarketDayHigh": 6.54, "beta": -0.757, "forwardPE": -2.9085429, "volume": 99080, "regularMarketVolume": 99080, "averageVolume": 208607, "averageVolume10days": 165380, "averageDailyVolume10Day": 165380, "bid": 5.61, "ask": 6.04, "bidSize": 100, "askSize": 100, "marketCap": 297194144, "fiftyTwoWeekLow": 4.42, "fiftyTwoWeekHigh": 18.4, "fiftyDayAverage": 8.1022, "twoHundredDayAverage": 10.010775, "currency": "USD", "enterpriseValue": 30701838, "floatShares": 16256299, "sharesOutstanding": 50976700, "sharesShort": 768333, "sharesShortPriorMonth": 797338, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.0150999995, "heldPercentInsiders": 0.13606, "heldPercentInstitutions": 0.83233, "shortRatio": 11.39, "shortPercentOfFloat": 0.02, "impliedSharesOutstanding": 50976700, "bookValue": 5.209, "priceToBook": 1.1192167, "lastFiscalYearEnd": 1698710400, "nextFiscalYearEnd": 1730332800, "mostRecentQuarter": 1722384000, "netIncomeToCommon": -123436000, "trailingEps": -1.46, "forwardEps": -1.69, "enterpriseToEbitda": -0.558, "52WeekChange": -0.17887324, "SandP52WeekChange": 0.2421279, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ENGN", "underlyingSymbol": "ENGN", "shortName": "enGene Holdings Inc.", "longName": "enGene Holdings Inc.", "firstTradeDateEpochUtc": 1643725800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f9f4e2ed-4011-3f93-916a-f8a188a8b358", "messageBoardId": "finmb_9516520", "gmtOffSetMilliseconds": -18000000, "currentPrice": 5.83, "targetHighPrice": 37.0, "targetLowPrice": 16.0, "targetMeanPrice": 27.22222, "targetMedianPrice": 30.0, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 257678000, "totalCashPerShare": 5.828, "ebitda": -54995000, "totalDebt": 24855000, "quickRatio": 19.165, "currentRatio": 19.52, "debtToEquity": 10.791, "returnOnAssets": -0.22067, "returnOnEquity": -1.23061, "freeCashflow": -23581124, "operatingCashflow": -35489000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-21"}]